Shareholding Pattern

• Shareholding Pattern for the Quarter ended 30th June 2026

Intimation of Board Meeting-

• Intimation of Board Meeting dated 14th July 2026
• Intimation of Board Meeting dated 02nd May 2026

Outcome of Board Meeting-

• Outcome of Board Meeting dated 20th July 2026
• Outcome of Board Meeting dated 8th May 2026

Financial Results-

• Financial Results-30th June 2026
• Financial Results-31st March 2026

Newspaper Publication for Results-

• Newspaper Publication for 30th June 2026 Results
• Newspaper Publication for 31st March 2026 Results

General Updates Under Regulation 30 of SEBI (LODR) Regulations, 2015-

• Intimation for Audio Recording of Earnings Call for Q1FY27
• Intimation for Grant of Employee Stock Options under “Bajaj Healthcare Limited Employee Stock Option Plan 2024”
• Earning updates for the quarter ended 30th June 2026
• Intimation for Earnings Call for Q1FY27
• The Company has received a recommendation from SEC-CDSCO to manufacture and market Cenobamate Tablets
• Intimation for Sale of Business Unit of the Company
• Earning updates for the quarter & year ended 31st March 2026
• Intimation of Approval received for Listing of 20,79,409 equity shares of ₹5/- each allotted pursuant to conversion of warrants issued on preferential basis

Annual Secretarial Compliance Report-

• Annual Secretarial Compliance Report for the financial year ended 31st March 2026

Trading Window Closure-

• Intimation for closure of Trading Window for the Quarter ended June 30, 2026

Compliance Certificate

• Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30th June 2026

Monitoring Agency Report

• Monitoring Agency Report Q1FY27

Integrated Filing (Financial)

• Integrated Filing for the quarter ended 30th June 2026

Statement of Deviation & Variation

• Statement of Deviation & Variation for the period ended 30th June 2026

Earnings Call 

• Audio Recording of Earnings call for Q1FY27